Taiarol, L., Formicola, B., Magro, R., Sesana, S., & Re, F. (2020). An update of nanoparticle-based approaches for glioblastoma multiforme immunotherapy. NANOMEDICINE, 1-11.

Gregori, M., Taylor, M., Salvati, E., Re, F., Mancini, S., Balducci, C., et al. (2017). Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide. NANOMEDICINE, 13(2), 723-732.

Zoia, C., Conti, E., Cereda, D., Rodriguez-Menendez, V., Andreoni, S., Gregori, M., et al. (2016). THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS. JOURNAL OF ALZHEIMER'S DISEASE.

Gregori, M., Orlando, A., Re, F., Sesana, S., Nardo, L., Salerno, D., et al. (2016). Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes. JOURNAL OF PHARMACEUTICAL SCIENCES, 105(1), 276-283.

Zoia, C., Conti, E., Ulisse, A., Rodriguez-Menendez, V., Gregori, M., Sesana, M.S., et al. (2015). Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease. In abstract book.